Eurasian Minerals, Inc. EMX 深 滬
等待開盤 08-21 09:30:00 美东时间
3.18
+0.010
+0.32%
華盛通- 最 高3.245
- 今 開3.20
- 成交量 21.07万股
- 最 低 3.16
- 昨 收 3.17
- 總市值 3.43亿
- 52周最高 3.39
- 市盈率 靜 --
- 換手率 0.20%
- 52周最低 1.59
- 委 比 -50.00%
- 總股本 1.08亿
- 歷史最高 3.81
- 量 比 0.65
- 振 幅 2.68%
- 歷史最低 0.67
- 每 手 1
- 風險率 0.43%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多HC Wainwright & Co. Maintains Buy on EMX Royalty, Raises Price Target to $5.75
HC Wainwright & Co. analyst Heiko F. Ihle maintains EMX Royalty (AMEX:EMX) with a Buy and raises the price target from $5 to $5.75.
08-13 18:45
EMX Royalty reports Q2 results, increases 2025 guidance
EMX Royalty press release (NYSE:EMX): Q2 revenue and other income of $14.7M. Adjusted royalty revenue of $19M and adjusted EBITDA of $12.1M. Outlook Updated 2025 Guidance Updated 2025 Guidance Orig...
08-12 05:37
亚马逊阿联酋站与7X集团达成战略合作
转自：商务部网站 据中东经济报近日报道，亚马逊阿联酋站与阿联酋7X集团达成战略合作，共同推进可持续的“最后一英里”配送。此次合作旨在利用7X旗下的物流部门EM...
07-11 11:04
EMX Royalty Forms Strategic Alliance with Avesoro, Sells Moroccan Portfolio
The latest announcement is out from EMX Royalty ( ($TSE:EMX) ). EMX Royalty Cor...
07-08 20:08
EMX Royalty Q1 EPS $0.01 Up From $(0.02) YoY, Sales $8.42M Up From $6.24M YoY
EMX Royalty (AMEX:EMX) reported quarterly earnings of $0.01 per share. This is a 150 percent increase over losses of $(0.02) per share from the same period last year. The company reported $8.42 million in sales this
05-13 05:53
美股大行评级 | Tigress Financial：维持爱彼迎"买入"评级，目标价从195美元升至200美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1107588488073326592.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.：维持ProQR Therapeutics(PRQR)"买入"评级，目标价从10美元升至12美元</p> <p>• Oppenheimer：上调内克塔治疗(NKTR)评级至"跑
03-17 10:10
Rubrik To Rally More Than 48%? Here Are 10 Top Analyst Forecasts For Friday
Top Wall Street analysts changed their outlook on these top names. For a comple...
03-14 19:40
美股大行评级 | 潜在涨幅71%！阿里巴巴获花旗上调目标价至138美元，维持“买入”评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1084758333929132032.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.：维持Inozyme Pharma(INZY)"买入"评级，目标价从14美元升至16美元</p> <p>• Maxim Group：上调Reviva Pharmaceutica
01-13 09:38
HC Wainwright & Co. Maintains Buy on EMX Royalty, Maintains $6.5 Price Target
HC Wainwright & Co. analyst Heiko Ihle maintains EMX Royalty (AMEX:EMX) with a Buy and maintains $6.5 price target.
2024-03-27 18:18
